TESTING AND ASSESSMENT

Get Seen. Get Tested. Get Treated.

Our dedicated CARE team comprised of doctors, pharmacists, nurses, and healthcare professionals is located in communities across Ontario. Our Mobile CARE Units, equipped with the most recent advances in diagnostic equipment, are available to go into remote areas where medical services are sparse and wait lists are long. We have invested in cutting-edge, non-invasive technology that can test and diagnose liver disease quickly.

If you or any of your loved ones are dealing with liver disease, please discuss with your family doctor for a referral to one of our Liver Care Centres, or contact us directly for more information.

FibroScan Technology
Painless And Non-Invasive

Fibroscan

Fibroscan® is the latest test available to accurately and non-invasively assess liver fibrosis and fatty infiltration. Fibroscan is a rapid, painless and non-invasive way to test your liver’s health.

World Health Organization

Working through offices in more than 150 countries, WHO staff work side by side with governments and other partners to ensure the highest attainable level of health for all people.

Key Facts About Hepatitis C

  • Hepatitis C is a liver disease caused by the hepatitis C virus: the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.

  • The hepatitis C virus is a bloodborne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.

  • Globally, between 130–150 million people have chronic hepatitis C infection.

  • A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.

  • Approximately 700 000 people die each year from hepatitis C-related liver diseases.

  • Antiviral medicines can cure approximately 90% of persons with hepatitis C infection, thereby reducing the risk of death from liver cancer and cirrhosis, but access to diagnosis and treatment is low.

  • There is currently no vaccine for hepatitis C; however research in this area is ongoing.